Alvogen nabs four Pfizer products; Brazil's pharma market to approach $48B by 2020: report;

> Alvogen has acquired a portfolio of four pharma products from Pfizer ($PFE). Release

> Brazil's pharma market will near $48 billion by 2020, GlobalData says. Release

> Amneal has created a new biosciences unit that will focus on injectables, oncologics, biosimilars and other products that have high barriers to entry. Release

> Mylan ($MYL) has launched a generic of Pfizer's anti-infective combo Zosyn. Release

> British health secretary Jeremy Hunt is to create tough new rules designed to criminalize some gifts and financial payments between doctors and pharma companies. Report

Suggested Articles

Novartis’ latest campaign with a celebrity dance partner asks people to bust a move to raise awareness around sickle cell anemia and therapy Adakveo.

Black Americans’ confidence in COVID-19 vaccines is dropping, with only 43% saying they will get a vaccine once it's out—down 22 points since August.

Bristol Myers Squibb and Exelixis will soon know whether their I-O/TKI combo gets a chance to challenge Merck and Pfizer's Keytruda-Inlyta regimen.